Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate the efficacy and safety of SHR-3167 compared with insulin glargine after treatment in insulin naïve subjects with type 2 diabetes treated with metformin alone or in combination with SGLT2 subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
273 participants in 3 patient groups
Loading...
Central trial contact
Jianting Han, B.S
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal